Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)
Primary Purpose
Kidney Calculi
Status
Unknown status
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Double Loop Ureteral stent endoscopic placement.
Sponsored by
About this trial
This is an interventional treatment trial for Kidney Calculi focused on measuring Double loop ureteral stent, USSQ, Quality of life, Pain
Eligibility Criteria
Inclusion Criteria:
- Male and female patients
- Aged > 18 years
- Unilateral renal non-infection stone for whom the treatment indication is a flexible ureterorenoscopy (multiple kidney stones are acceptable provided that only one side is currently symptomatic)
- Index stone of 5-25 mm (measured on plain abdomen X-Ray KUB or CT)
- Without any currently implanted JJ stent
- Patient agreed to participate to the study and having signed the consent form
- Able to complete self-rated questionnaires.
Exclusion Criteria:
- Acute ureteric/nephritic colic (residual pain is acceptable)
- Any type of chronic pain
- Large stones > 25 mm
- Infection renal stone already diagnosed and documented
- Malformation of urinary tract (e.g. Horseshoe kidney, duplicity or, ureterocele, mega ureter)
- Diverticulum stone
- Urogenital tumor
- Any significant neurological disease or injury impacting sensation
- JJ stents already implanted
- Patients with long-term indwelling urethral catheter
- No indication for JJ insertion (e.g. spontaneous stone passage)
- Untreated urinary tract infection
- Ureteral obstruction (stenosis, compression, calculi)
- Neurogenic bladder
- Overactive bladder
- Bladder stone
- Chronic prostatitis
- BPH treated (recent initiation of 5 alpha-Reductase Inhibitor or Phytotherapeutic agents)
- Ongoing Alpha-Blocker or Anticholinergic medication
- Pregnancy
- Any event discovered during the endoscopy which is not compatible with the study design and objective
Sites / Locations
- Service de Chirurgie Urologique de l'Hôpital TenonRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Coloplast Hydrocoated silicone JJ stent
Boston Percuflex Plus JJ stent
Arm Description
Double loop ureteral stent endoscopic placement
Double loop ureteral stent endoscopic placement
Outcomes
Primary Outcome Measures
USSQ scale (Ureteral Stent Symptoms Questionnaire)
Secondary Outcome Measures
Evaluate impact on quality of life via the USSQ questionnaire assessing 5 other scores and adverse event reporting at all visits.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02489656
Brief Title
Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)
Official Title
Effect of a Silicone Hydrocoated Double Loop Ureteral Stent on Symptoms and Quality of Life in Patients Undergoing F-URS for Kidney Stone; a Comparative Randomized Multicenter Clinical Study.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Unknown status
Study Start Date
September 2013 (undefined)
Primary Completion Date
December 2016 (Anticipated)
Study Completion Date
December 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coloplast A/S
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is a prospective, randomized multicenter study conducted in Europe. It is designed to compare two double loop ureteral stents in terms of the quality of life in patients operated on a kidney stone and requiring the placement of a double loop ureteral stent at the end of the operation.
Detailed Description
The double loop stents are used for both prevention and treatment of ureteral obstruction: They permit the interim internal bypass drainage of urine when obstruction in the ureter especially in cases of lithiasis or after surgical intervention on the upper urinary tract.
There are many indications for double loop stent placement and population chosen for this study are adult patients with intra-renal calcium calculi of 7-20 mm in diameter for whom the treatment indication is a flexible ureterorenoscopy.
The aims of the use of a double loop stent are to
prevent complications (pain, infection) associated with the ureteral obstruction by any residual stone fragments, blood clot or local oedema generated by the intervention.
preserve the renal function.
facilitate healing process while limiting the risk of stenosis and probably reduce the rate of readmission after patients' discharge.
Double loop Stent-related symptoms have a high prevalence and may affect over 80% of patients.
Assessment tools are important to determine the symptoms intensity and allow for comparisons at different times. The Urinary Stent Symptom Questionnaire (USSQ) is the most adapted tool designed for this purpose.
An ideal ureteral stent is expected to drain well, to be easy to insert and to be comfortable for the patients. The investigators designed a hydro-coated Silicone JJ stent with additional properties for improving patient's comfort.
The investigators decided to perform a randomized clinical investigation to evaluate the Coloplast Hydrocoated Silicone JJ in comparison to the Boston Percuflex Plus JJ stent on patients' comfort.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Calculi
Keywords
Double loop ureteral stent, USSQ, Quality of life, Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
140 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Coloplast Hydrocoated silicone JJ stent
Arm Type
Experimental
Arm Description
Double loop ureteral stent endoscopic placement
Arm Title
Boston Percuflex Plus JJ stent
Arm Type
Active Comparator
Arm Description
Double loop ureteral stent endoscopic placement
Intervention Type
Device
Intervention Name(s)
Double Loop Ureteral stent endoscopic placement.
Intervention Description
A JJ stent placement may be indicated at the end of the endourological removal of kidney stones to ensure urine drainage and cicatrisation
Primary Outcome Measure Information:
Title
USSQ scale (Ureteral Stent Symptoms Questionnaire)
Time Frame
at day 20
Secondary Outcome Measure Information:
Title
Evaluate impact on quality of life via the USSQ questionnaire assessing 5 other scores and adverse event reporting at all visits.
Time Frame
Day 2, 7 and 35
Other Pre-specified Outcome Measures:
Title
Encrustation of double loop ureteral stents
Description
Encrustation of double loop ureteral stents is evaluated by a score of integer values ranging from 0 to 6
Time Frame
after 20 days (JJ stent removal)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male and female patients
Aged > 18 years
Unilateral renal non-infection stone for whom the treatment indication is a flexible ureterorenoscopy (multiple kidney stones are acceptable provided that only one side is currently symptomatic)
Index stone of 5-25 mm (measured on plain abdomen X-Ray KUB or CT)
Without any currently implanted JJ stent
Patient agreed to participate to the study and having signed the consent form
Able to complete self-rated questionnaires.
Exclusion Criteria:
Acute ureteric/nephritic colic (residual pain is acceptable)
Any type of chronic pain
Large stones > 25 mm
Infection renal stone already diagnosed and documented
Malformation of urinary tract (e.g. Horseshoe kidney, duplicity or, ureterocele, mega ureter)
Diverticulum stone
Urogenital tumor
Any significant neurological disease or injury impacting sensation
JJ stents already implanted
Patients with long-term indwelling urethral catheter
No indication for JJ insertion (e.g. spontaneous stone passage)
Untreated urinary tract infection
Ureteral obstruction (stenosis, compression, calculi)
Neurogenic bladder
Overactive bladder
Bladder stone
Chronic prostatitis
BPH treated (recent initiation of 5 alpha-Reductase Inhibitor or Phytotherapeutic agents)
Ongoing Alpha-Blocker or Anticholinergic medication
Pregnancy
Any event discovered during the endoscopy which is not compatible with the study design and objective
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pascale HS Holliday, CTM
Phone
+33 1 40 83 68 58
Email
frpho@coloplast.com
First Name & Middle Initial & Last Name or Official Title & Degree
Dorothee Behr, Med Manager
Phone
+33 1 40 83 68 50
Email
frdbe@coloplast.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivier PJ Traxer, Professor
Organizational Affiliation
Service de Chirurgie Urologique de l'Hôpital Tenon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Chirurgie Urologique de l'Hôpital Tenon
City
Paris
ZIP/Postal Code
75020
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier PJ Traxer, Professor
Phone
33 1 56 01 61 53.
Email
olivier.traxer@tnn.aphp.fr
12. IPD Sharing Statement
Learn more about this trial
Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)
We'll reach out to this number within 24 hrs